NBIX
Neurocrine Biosciences Inc
141.30$
-1.5%
vs. previous close
Closing price · As of: Oct 8, 2026
Statements
Income Statement
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 16 | Q4 16 | Q1 17 | Q2 17 | Q3 17 | Q4 17 | Q1 18 | Q2 18 | Q3 18 | Q4 18 | Q1 19 | Q2 19 | Q3 19 | Q4 19 | Q1 20 | Q2 20 | Q3 20 | Q4 20 | Q1 21 | Q2 21 | Q3 21 | Q4 21 | Q1 22 | Q2 22 | Q3 22 | Q4 22 | Q1 23 | Q2 23 | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | +0.0% | -100.0% | – | +859.3% | +55.5% | -24.8% | +36.3% | +56.6% | -13.4% | +5.3% | +32.6% | +21.0% | +9.9% | -2.8% | +27.5% | -14.5% | -4.1% | -4.6% | +22.1% | +2.5% | +5.4% | -0.4% | +21.8% | +2.6% | +6.2% | +2.0% | +7.7% | +10.2% | +3.3% | +0.0% | +14.5% | +5.4% | +0.9% | -8.8% | +20.1% | +15.6% | +1.3% | +1.1% | +17.7% | – | |
| – | +20.5% | +7.9% | -99.9% | +609.8% | +75.5% | +25.0% | -10.1% | +81.6% | -1.1% | -28.3% | +45.5% | +37.5% | +11.9% | -14.7% | +14.3% | +12.5% | +7.4% | +0.0% | +6.9% | +35.5% | -2.4% | +12.2% | +4.3% | +27.1% | +26.2% | +10.4% | +35.3% | -2.6% | -24.1% | -11.8% | +22.7% | -13.0% | +16.3% | -1.1% | +22.8% | +23.9% | +25.7% | -21.6% | +68.1% | – | |
| – | – | – | – | +861.8% | +55.4% | -25.2% | +36.9% | +56.4% | -13.5% | +5.6% | +32.5% | +20.9% | +9.8% | -2.7% | +27.7% | -14.7% | -4.2% | -4.6% | +22.3% | +2.1% | +5.5% | -0.6% | +22.0% | +2.2% | +5.9% | +1.9% | +7.1% | +10.5% | +3.9% | +0.2% | +14.4% | +5.7% | +0.7% | -8.9% | +20.0% | +15.5% | +0.9% | +1.6% | +16.9% | – | |
| – | +7.8% | +129.7% | -57.9% | +2.7% | +14.0% | +91.1% | -24.4% | -4.1% | +10.2% | -3.6% | +63.7% | -26.6% | +22.4% | +5.2% | +38.8% | -14.6% | -3.5% | +9.7% | +2.2% | +23.9% | -5.7% | +16.9% | +33.0% | -20.8% | +9.6% | +18.2% | +4.5% | -2.5% | -3.3% | +15.9% | +19.9% | +2.0% | -4.8% | +41.8% | -7.2% | +2.3% | +3.3% | +14.7% | +10.3% | – | |
| – | +35.3% | +18.5% | +48.6% | +5.3% | +28.3% | +4.1% | +3.9% | -0.8% | +14.2% | +26.9% | -7.7% | +4.5% | +199.3% | -53.4% | -18.1% | +16.6% | -5.3% | +21.1% | +11.0% | +8.0% | +1.2% | +28.2% | -8.9% | +1.9% | -1.8% | +32.7% | -8.6% | -7.9% | +7.2% | +11.1% | -0.5% | -3.2% | +22.8% | -3.9% | +3.5% | +1.9% | +3.5% | +5.5% | +38.1% | – | |
| – | +20.3% | +72.8% | -20.5% | +4.4% | +23.5% | +31.3% | -9.0% | -2.1% | +12.7% | +120.5% | -38.1% | -12.0% | +48.6% | -8.7% | +26.9% | +34.3% | -42.3% | +16.7% | +10.3% | +10.9% | -1.4% | +24.2% | +5.2% | -7.8% | +2.3% | +74.8% | -30.1% | -5.8% | +2.9% | +14.6% | +6.6% | -1.2% | +10.7% | +13.3% | -1.7% | +2.1% | +6.5% | +6.5% | +27.3% | – | |
| – | – | – | – | – | – | -416.4% | – | – | -59.7% | -561.8% | – | +161.9% | -45.9% | +20.9% | +30.1% | -157.8% | – | -56.1% | +99.4% | -29.1% | +43.8% | -95.2% | +1,664.5% | +60.5% | +17.8% | -210.4% | – | +91.8% | +6.4% | -33.9% | +46.4% | +26.4% | -22.7% | -83.4% | +516.9% | +64.1% | -11.8% | -11.8% | -17.7% | – | |
| – | – | -100.0% | – | +53.9% | +1.1% | +1.1% | +1.2% | +1.1% | +1.2% | +1.2% | +1.1% | +1.2% | +1.1% | +0.9% | +1.2% | +2.4% | -8.2% | -17.9% | -3.1% | +6.5% | +0.0% | -60.6% | -15.4% | -45.5% | -8.3% | +0.0% | +18.2% | -15.4% | +0.0% | +0.0% | +4,418.2% | – | – | – | – | – | – | – | – | – | |
| – | – | – | – | – | – | -706.6% | – | – | -63.0% | -645.5% | – | +12.1% | -33.9% | +0.8% | +113.9% | -168.6% | – | -34.8% | +111.4% | -47.0% | -145.2% | – | -208.9% | – | +20.4% | -187.6% | – | -4.9% | +71.5% | -82.6% | +185.8% | +93.0% | -14.6% | -91.0% | +985.0% | +82.9% | -18.0% | +3.1% | -34.3% | – | |
| – | – | – | – | +53.9% | -8.9% | +12.2% | +1.2% | +1.1% | -90.5% | -165.6% | – | +513.3% | -0.4% | -67.4% | +140.0% | -86.1% | -61,340.0% | – | – | -47.4% | -181.3% | – | -185.3% | – | -1.7% | -192.4% | – | +24.5% | +55.4% | -117.6% | – | +80.1% | -1.7% | -88.6% | +664.7% | +58.3% | +4.1% | -42.9% | -63.6% | – | |
| – | – | – | – | – | – | -706.6% | – | – | -64.4% | -664.9% | – | +4.8% | -36.8% | +10.0% | +112.8% | -172.4% | – | -90.8% | +31.8% | -46.8% | -132.4% | – | -221.6% | – | +29.9% | -186.1% | – | -13.0% | +77.7% | -70.6% | +49.8% | +99.7% | -20.6% | -92.3% | +1,260.8% | +94.9% | -26.6% | +28.8% | -27.0% | – | |
| – | – | – | – | – | – | -323.2% | – | +2,223.9% | -53.2% | -434.3% | – | +10.7% | -28.6% | +0.7% | +90.2% | -149.6% | – | -30.2% | +83.7% | -39.8% | -110.5% | – | -163.0% | – | +19.7% | -178.8% | – | -3.6% | +67.8% | -45.6% | +39.2% | +23.3% | -5.0% | -82.8% | +432.9% | +79.6% | -21.4% | -17.9% | -1.8% | – |
LTM = last twelve months (sum of the four most recent quarters).
Showing the most recent 40 periods — older statements are on file for this stock.
Data as of: October 8, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.